companydata.dkcompanydata.dk

CONRIG PHARMA ApS: Financial statements 2022

CVR: 33373236

Source: annual report 2022, Danish Business Authority

01/01/202231/12/2022

CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,265,932 and a net result of DKK 1,244,502 compared with DKK -308,167 the year before. Equity in the 2022 report amounted to DKK 409,025. The solvency ratio was 34.2%.

Gross Profit
DKK 1,265,932
Profit/Loss
DKK 1,244,502
Equity
DKK 409,025
Total Assets
DKK 1,194,994

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.3 mio.1.2 mio.409 t.-
2021--246 t.-308 t.-1.7 mio.-
2020--555 t.-604 t.-1.4 mio.-
2019--165 t.-198 t.-793 t.-
2018--388 t.-398 t.-595 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CONRIG PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Snickar Karl Johan Tobieson joins the board of CONRIG PHARMA ApSNov 28, 2022

As of November 28, 2022, Snickar Karl Johan Tobieson has joined the board of directors of CONRIG PHARMA ApS.

Lars Christer Fredrik Fåhraeus joins the board of CONRIG PHARMA ApSNov 28, 2022

As of November 28, 2022, Lars Christer Fredrik Fåhraeus has joined the board of directors of CONRIG PHARMA ApS.

John Bondo Hansen leaves the board of CONRIG PHARMA ApSNov 28, 2022

As of November 28, 2022, John Bondo Hansen has left the board of directors of CONRIG PHARMA ApS.

Mikael Søndergaard Thomsen leaves the board of CONRIG PHARMA ApSNov 28, 2022

As of November 28, 2022, Mikael Søndergaard Thomsen has left the board of directors of CONRIG PHARMA ApS.

Snickar Karl Johan Tobieson joins CONRIG PHARMA ApS as directorNov 28, 2022

As of November 28, 2022, Snickar Karl Johan Tobieson is registered as director of CONRIG PHARMA ApS.

Lars Christer Fredrik Fåhraeus joins CONRIG PHARMA ApS as directorNov 28, 2022

As of November 28, 2022, Lars Christer Fredrik Fåhraeus is registered as director of CONRIG PHARMA ApS.

John Bondo Hansen steps down as director of CONRIG PHARMA ApSNov 28, 2022

As of November 28, 2022, John Bondo Hansen has stepped down as director of CONRIG PHARMA ApS.

Mikael Søndergaard Thomsen steps down as director of CONRIG PHARMA ApSNov 28, 2022

As of November 28, 2022, Mikael Søndergaard Thomsen has stepped down as director of CONRIG PHARMA ApS.

CONRIG PHARMA ApS: The 2021 annual report is outApr 19, 2022

CONRIG PHARMA ApS has published its annual report for 2021. Gross profit came to DKK -246,326, and the net result was DKK -308,167.

Registered as owner of CONRIG PHARMA ApSFeb 8, 2022

As of February 8, 2022, is registered as an owner of CONRIG PHARMA ApS with an ownership share of 100%.

About CONRIG PHARMA ApS

CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Lars Christer Fredrik Fåhraeus and Snickar Karl Johan Tobieson. The board consists of Lars Christer Fredrik Fåhraeus, Niels Skjærbæk and Snickar Karl Johan Tobieson. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.

Source: annual report 2025, Danish Business Authority